重药控股
(000950)
| 流通市值：94.89亿 | | | 总市值：94.89亿 |
| 流通股本：17.13亿 | | | 总股本：17.13亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 40,131,616,668.67 | 20,432,336,918.06 | 82,447,409,172.78 | 62,211,401,881.27 |
| 营业总成本 | 39,510,767,839.97 | 20,054,289,006.03 | 81,307,114,714.58 | 61,116,440,262.49 |
| 其他经营收益 | | | | |
| 营业利润 | 408,810,194.61 | 244,552,890.64 | 682,870,625.94 | 665,170,780.07 |
| 利润总额 | 418,130,427.66 | 245,280,673.7 | 671,859,537.7 | 657,436,219.76 |
| 净利润 | 312,530,169.22 | 198,365,905.39 | 521,328,438.97 | 532,377,823.31 |
| 每股收益 | | | | |
| 其他综合收益 | -442,023.47 | - | -2,590,237 | -7,482,030.39 |
| 综合收益总额 | 312,088,145.75 | 198,365,905.39 | 518,738,201.97 | 524,895,792.92 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 58,690,896,439.79 | 59,316,651,686.69 | 56,951,600,796.6 | 58,455,643,236.54 |
| 非流动资产: | | | | |
| 非流动资产合计 | 9,384,115,166.76 | 9,478,578,494.21 | 9,287,894,627.98 | 9,256,815,940.87 |
| 资产总计 | 68,075,011,606.55 | 68,795,230,180.9 | 66,239,495,424.58 | 67,712,459,177.41 |
| 流动负债: | | | | |
| 流动负债合计 | 49,481,391,767.41 | 49,601,077,806.08 | 46,740,735,682.96 | 47,396,940,496.57 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,881,967,762.45 | 2,447,428,796.82 | 2,944,323,025.55 | 3,841,239,275.29 |
| 负债合计 | 51,363,359,529.86 | 52,048,506,602.9 | 49,685,058,708.51 | 51,238,179,771.86 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 11,739,099,630.99 | 11,707,134,343.71 | 11,536,404,619.63 | 11,556,221,592.67 |
| 股东权益合计 | 16,711,652,076.69 | 16,746,723,578 | 16,554,436,716.07 | 16,474,279,405.55 |
| 负债和股东权益合计 | 68,075,011,606.55 | 68,795,230,180.9 | 66,239,495,424.58 | 67,712,459,177.41 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 43,794,297,865.94 | 20,609,992,899.9 | 94,595,955,218.15 | 66,990,294,029.22 |
| 经营活动现金流出小计 | 47,403,727,196.41 | 23,926,167,813.32 | 93,841,285,128.77 | 69,320,559,190.62 |
| 经营活动产生的现金流量净额 | -3,609,429,330.47 | -3,316,174,913.42 | 754,670,089.38 | -2,330,265,161.4 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 163,531,860.01 | 13,734,551.88 | 518,315,307.25 | 235,235,365.76 |
| 投资活动现金流出小计 | 189,362,713.7 | 99,833,118.4 | 354,566,834.26 | 296,998,614.76 |
| 投资活动产生的现金流量净额 | -25,830,853.69 | -86,098,566.52 | 163,748,472.99 | -61,763,249 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 13,879,349,031.21 | 6,227,873,249.94 | 25,383,884,483.61 | 17,966,913,059.01 |
| 筹资活动现金流出小计 | 11,368,044,487.63 | 4,051,329,724.95 | 26,338,319,304.31 | 18,635,288,653.81 |
| 筹资活动产生的现金流量净额 | 2,511,304,543.58 | 2,176,543,524.99 | -954,434,820.7 | -668,375,594.8 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -1,123,955,640.58 | -1,225,729,954.95 | -36,016,258.33 | -3,060,404,005.2 |
| 期末现金及现金等价物余额 | 3,627,010,675.33 | 3,525,236,360.96 | 4,750,966,315.91 | 1,726,578,569.04 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -1,123,955,640.58 | - | -36,016,258.33 | - |